Comparison of antibiograms developed for inpatients and primary care outpatients

Diagn Microbiol Infect Dis. 2013 May;76(1):73-9. doi: 10.1016/j.diagmicrobio.2013.01.026. Epub 2013 Mar 27.

Abstract

To support antimicrobial stewardship, some healthcare systems have begun creating outpatient antibiograms. We developed inpatient and primary care outpatient antibiograms for a regional health maintenance organization (HMO) and academic healthcare system (AHS). Antimicrobial susceptibilities from 16,428 Enterococcus, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa cultures from 2010 were summarized and compared. Methicillin susceptibility among S. aureus was similar in inpatients and primary care outpatients (HMO: 61.2% versus 61.9%, P = 0.951; AHS: 62.9% versus 63.3%, P > 0.999). E. coli susceptibility to trimethoprim/sulfamethoxazole was also similar (HMO: 81.8% versus 83.6%, P = 0.328; AHS: 77.2% versus 80.9%, P = 0.192), but ciprofloxacin susceptibility differed (HMO: 88.9% versus 94.6%, P < 0.001; AHS: 81.2% versus 90.6%, P < 0.001). In the HMO, ciprofloxacin-susceptible P. aeruginosa were more frequent in primary care outpatients than in inpatients (91.4% versus 79.0%, P = 0.007). Comparison of cumulative susceptibilities across settings yielded no consistent patterns; therefore, outpatient primary care antibiograms may more accurately inform prudent empiric antibiotic prescribing.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Ambulatory Care / methods
  • Ciprofloxacin / therapeutic use
  • Drug Resistance, Multiple, Bacterial*
  • Enterococcus / drug effects
  • Enterococcus / isolation & purification
  • Escherichia coli / drug effects*
  • Escherichia coli / isolation & purification
  • Female
  • Health Maintenance Organizations
  • Humans
  • Inpatients*
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / isolation & purification
  • Male
  • Methicillin / therapeutic use
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification
  • Microbial Sensitivity Tests*
  • Middle Aged
  • Outpatients*
  • Primary Health Care / methods*
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / isolation & purification
  • Retrospective Studies
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / isolation & purification
  • Young Adult

Substances

  • Ciprofloxacin
  • Methicillin